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Inhibiting sodium-dependent glucose transporters
(SGLTs) has been proposed as a new therapy for the
treatment of diabetes [1]. SGLT2 as the most prominent
member of this family is mainly expressed in the kidney
and responsible for the reabsorption of the vast majority
of the filtered glucose. This key role in the blood glu-
cose homeostasis makes SGLT2 a promising target
which has been clearly underlined by the results of pre-
clinical and clinical studies. Therapeutic goals of SGLT2
inhibition are reduced plasma glucose levels and weight
loss. In conjunction with the therapeutic benefits fewer
side effects are expected than observed with other
known diabetes drugs. Potential side effects in case of
SGLT2 inhibition are expected to be mediated by a lack
of selectivity towards SGLT1 that is mainly expressed in
the intestine and responsible for glucose- and galactose
absorption from food sources. Therefore, inhibition of
SGLT1 leads to glucose- and galactose malabsorption,
dehydration, and diarrhoea.
Consequently, any drug discovery project aiming for
promising SGLT2 inhibitors has to take into account sig-
nificant selectivity towards SGLT1. In order to describe
the selectivity on a structural basis we extensively used
molecular modelling techniques since no x-ray structural
data is available for neither SGLT1 nor SGLT2. For both
transporters homology models were generated using the
published x-ray structure from vSGLT (PDB-code 3DH4)
[2]. Structure based alignments of published SGLT2 inhi-
bitors including selectivity data for SGLT1 were followed
by 3D-QSAR studies utilizing CoMFA fields. Given a
detailed analysis of the inhibitor SAR for both transporters
the two structural models of SGLT1 and SGLT2 were
compared leading to the identification of relevant differ-
ences and selectivity hot spots. In the future, the presented
models could serve as a basis for the identification of new
potent SGLT2 inhibitors that are selective towards
SGLT1, too.
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